Oklahoma HB 3731: Cost transparency in diabetes treatments; definitions; reporting; report contents; prescription drugs; effective date.

Status: Second Reading referred to Public Health (as of 2022-02-08)

State: Oklahoma · Session: 2022 · Bill: HB 3731

Sponsors: West (Josh)

View Oklahoma HB 3731 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.